Break Up Big Medicine Act Would Force CVS Health To Spin Off PBM And Provider Units Within 12 Months
Billionaire Mark Cuban backed the Break Up Big Medicine Act, which would force CVS Health to spin off its PBM and provider units within one year. Enforceable by the FTC and DOJ with profit-disgorgement penalties, the bill threatens CVS’s integrated operations and could materially alter its revenue composition.
1. Cuban Endorsement
Mark Cuban publicly praised the bipartisan Break Up Big Medicine Act on social media, urging presidential support to lower American healthcare costs. His endorsement highlights growing pressure on policymakers to dismantle integrated healthcare conglomerates.
2. Key Provisions of the Bill
Modeled after the 1933 Glass-Steagall Act, the legislation would prohibit common ownership between insurers, pharmacy benefit managers and provider networks. CVS Health would be required to divest its PBM arm and clinical subsidiaries within 12 months or face profit-disgorgement penalties.
3. Potential Impact on CVS Health
Mandated spin-offs could disrupt CVS’s vertically integrated model, altering its revenue mix and synergies between retail pharmacies, pharmacy benefits and care delivery. Investors may reassess the company’s valuation based on reduced scale, higher compliance costs and potential margin contraction.